SECOND SIGHT MEDICAL PRODUCT (EYES) Stock Analyst Ratings
NASDAQ:EYES - Nasdaq - US81362J3086 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to EYES. The Buy consensus is the weighted average rating of the current analysts ratings.
EYES was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EYES.
In the previous month the buy percentage consensus was at a similar level.
EYES was analyzed by 7 analysts. More opinions would make the average more meaningful.